Morning Read: BioMarin pulls plug on $680M Duchenne drug, Valeant’s Pearson cashes in
Plus, health insurance startup Oscar to build concierge clinic in Arizona, AIDS Healthcare Foundation wants the FDA and Congress to investigate Gilead and eHealth hires its new CEO from Playboy.